Upload
PPT-Figure Figure.  Cases of yellow fever vaccine–associated viscerotropic

PPT-Figure Figure.  Cases of yellow fever vaccine–associated viscerotropic

Author : brianna | Published Date : 2023-09-06

Seligman SJ Yellow Fever Virus Vaccineassociated Deaths in Young Women Emerg Infect Dis 2011171018911893 httpsdoiorg103201eid1710101789

woman age yellow amp age woman amp yellow fever young

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Figure Figure.  Cases of yellow..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Figure Figure.  Cases of yellow fever vaccine–associated viscerotropic: Transcript

Seligman SJ Yellow Fever Virus Vaccineassociated Deaths in Young Women Emerg Infect Dis 2011171018911893 httpsdoiorg103201eid1710101789. Outbreak . in . the WHO African Region. : . What . has been . done?. Dr Ambrose Talisuna, WHO-Regional Office for Africa-AFRO. Brazzaville-Congo. . Presentation outline. Introduction. Yellow Fever . Lam C, Octavia S, Ricafort L, Sintchenko V, Gilbert GL, Wood N, et al. Rapid Increase in Pertactin-deficient Bordetella pertussis Isolates, Australia. Emerg Infect Dis. 2014;20(4):626-633. https://doi.org/10.3201/eid2004.131478. What’s the difference?. 1 severe reaction. Reported in . 2016. Adverse reactions to general vaccines: 0.13 per 100,000 doses. 33 . anaphylaxis. . reports (25.1 million doses) . Reaction time: . immediately up to the next day. All India institute of Medical sciences Bhubaneswar  Venue: Room No - 5 2, Block – C, OPD complex.  Vaccination is provided on every Monday & Thursday (working day).  Registration ti Page 1of 8 Yellow Fever Vaccine YF-VAX¨ YF-VAX¨, Yellow Fever Vaccine, for subcutaneous use, is prepared by culturing the 17D-204 strain ofyellow fever virus in livingavian leukosis virus-free (ALV- Please cite this article in press as: Martins RdM, et al. Adverse events yellow fever immunization: Report and analysis of 67neurological cases in Brazil. Vaccine (2014), http://dx.doi.org/10.1016/j.v Rahimi P, Sohrabi A, Ashrafihelan J, Edalat R, Alamdari M, Masoudi M, et al. Emergence of African Swine Fever Virus, Northwestern Iran. Emerg Infect Dis. 2010;16(12):1946-1948. https://doi.org/10.3201/eid1612.100378. Ooi E, Goh K, Gubler DJ. Dengue Prevention and 35 Years of Vector Control in Singapore. Emerg Infect Dis. 2006;12(6):887-893. https://doi.org/10.3201/eid1206.051210. Lau CL, DePasquale JM. Leptospirosis Diagnostic Challenges, American Samoa. Emerg Infect Dis. 2012;18(12):2079-2081. https://doi.org/10.3201/eid1812.120429. Rovery C, Brouqui P, Raoult D. Questions on Mediterranean Spotted Fever a Century after Its Discovery. Emerg Infect Dis. 2008;14(9):1360-1367. https://doi.org/10.3201/eid1409.071133. van Woerden HC, Mason BW, Nehaul LK, Smith R, Salmon RL, Healy B, et al. Q Fever Outbreak in Industrial Setting. Emerg Infect Dis. 2004;10(7):1282-1289. https://doi.org/10.3201/eid1007.030536. Mahara F. Japanese Spotted Fever: Report of 31 Cases and Review of the Literature. Emerg Infect Dis. 1997;3(2):105-111. https://doi.org/10.3201/eid0302.970203. Kaydos-Daniels SC, Olowokure B, Chang H, Barwick RS, Deng J, Lee M, et al. Body Temperature Monitoring and SARS Fever Hotline, Taiwan. Emerg Infect Dis. 2004;10(2):373-376. https://doi.org/10.3201/eid1002.030748. Houseman C, Hughes GJ, Chapman KE, Wilson D, Gorton R. Increased Invasive Pneumococcal Disease, North East England, UK. Emerg Infect Dis. 2017;23(1):122-126. https://doi.org/10.3201/eid2301.160897.

Download Document

Here is the link to download the presentation.
"Figure Figure.  Cases of yellow fever vaccine–associated viscerotropic"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents

Figure 1 Figure 1. . . Pertussis cases/100,000 population in Australia, 2008–20012,

Figure 1 Figure 1. . . Pertussis cases/100,000 population in Australia, 2008–20012,
Yellow Fever Well-documented Adverse reactions

Yellow Fever Well-documented Adverse reactions
Yellow Fever Vaccination Centre

Yellow Fever Vaccination Centre
HFS Category 8012

HFS Category 8012
following

following
Figure Figure. Acute form of African swine fever in wild boars. A) Petechial

Figure Figure. Acute form of African swine fever in wild boars. A) Petechial
Figure 1 Figure 1. Annual incidence dengue fever (DF) and dengue hemorrhagic

Figure 1 Figure 1. Annual incidence dengue fever (DF) and dengue hemorrhagic
Figure Figure. Clinical course of temperature and selected laboratory results in a patient

Figure Figure. Clinical course of temperature and selected laboratory results in a patient
Figure 4 Figure 4. Distribution of the cases of Mediterranean spotted fever (MSF)

Figure 4 Figure 4. Distribution of the cases of Mediterranean spotted fever (MSF)
Figure 3 Figure 3. Relative risks for employees at various machines on the factory

Figure 3 Figure 3. Relative risks for employees at various machines on the factory
Figure 1 Figure 1. Fever and clinical course, 62-year-old woman.

Figure 1 Figure 1. Fever and clinical course, 62-year-old woman.
Figure 2 Figure 2. Advice given to callers to severe acute respiratory syndrome

Figure 2 Figure 2. Advice given to callers to severe acute respiratory syndrome
Figure 2 Figure 2. Trends in incidence of serotypes causing invasive pneumococcal disease

Figure 2 Figure 2. Trends in incidence of serotypes causing invasive pneumococcal disease